News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
ImClone Systems Incorporated Says Its Cancer Drug Works as Initial Treatment
June 20, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHICAGO — Two biotechnology giants did battle here at the nation’s largest cancer conference over the weekend. And both remained standing.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 3
MORE ON THIS TOPIC
Insights
Your Scale, Your Terms: How Modular Bioreactors Are Redefining Capacity & Manufacturing Strategies
April 13, 2026
·
7 min read
·
Jennifer C. Smith-Parker
Regulatory
GSK again pulls application for leucovorin, touted by FDA as potential autism treatment
April 10, 2026
·
2 min read
·
Tristan Manalac
Insights
Automation, Collaboration and the Future of Advanced Therapies
April 9, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Dermatology
Insmed Scraps Skin Plans for Lung Disease Drug as Competitors Make Headway
April 8, 2026
·
2 min read
·
Tristan Manalac
